Zydus Lifesciences Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Particulars | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | Mar '2020 |
---|---|---|---|---|---|
Debt-Equity Ratio | 0.37 | 0.28 | 0.25 | 0.32 | 0.37 |
Long Term Debt-Equity Ratio | 0.32 | 0.15 | 0.03 | 0.09 | 0.18 |
Current Ratio | 2.58 | 1.86 | 1.38 | 1.26 | 1.36 |
Fixed Assets | 1.30 | 1.11 | 1.07 | 1.15 | 1.00 |
Inventory | 6.24 | 4.71 | 4.23 | 4.90 | 4.43 |
Debtors | 2.62 | 3.02 | 3.75 | 3.57 | 2.78 |
Interest Cover Ratio | 11.85 | 8.30 | 12.02 | 27.51 | 7.91 |
PBIDTM (%) | 47.46 | 32.06 | 26.80 | 30.87 | 35.92 |
PBITM (%) | 42.80 | 26.46 | 20.69 | 25.07 | 29.16 |
PBDTM (%) | 43.85 | 28.87 | 25.07 | 29.96 | 32.23 |
CPM (%) | 36.47 | 23.11 | 20.09 | 26.79 | 29.02 |
APATM (%) | 31.81 | 17.51 | 13.98 | 20.99 | 22.26 |
ROCE (%) | 22.73 | 13.31 | 9.84 | 12.22 | 13.53 |
RONW (%) | 23.45 | 11.38 | 8.43 | 13.61 | 14.25 |